Polysaccharopeptide exerts immunoregulatory effects via MyD88-dependent signaling pathway

International Journal of Biological Macromolecules

Volumn 82, Issue , 2016, Pages 201-207

  Feng, Zifang ^a   Wang, Zhixue ^a   Yang, Min ^b   Zhou, Lijing ^a   Bao, Yixi ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Anti tumor; MyD88 dependent; Polysaccharopeptide

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; POLYSACCHAROPEPTIDE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOLOGIC FACTOR; POLYSACCHARIDE PEPTIDE; PROTEOGLYCAN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; EHRLICH ASCITES TUMOR; FEMALE; IMMUNOMODULATION; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROTEIN EXPRESSION; SPLEEN; THYMUS; ANIMAL; CARCINOMA, EHRLICH TUMOR; CYTOTOXICITY; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; MACROPHAGES; MICE; MYELOID DIFFERENTIATION FACTOR 88; PROTEOGLYCANS; SIGNAL TRANSDUCTION; SPLEEN; THYMUS GLAND; TOLL-LIKE RECEPTOR 4; TUMOR BURDEN;

EID: 84951733058     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2015.11.002     Document Type: Article

References (34)

1. Stevens R.G., Brainard G.C., Blask D.E., Lockley S.W., Motta M.E. CA: Cancer J. Clin. 2014, 64:207-218.
2. Zhong Y., Zou J., Zhang L. Liaoning J. Tradit. Chin. Med. 2001, 28:668-669.
3. Yeung J.H., Or P.M. Phytomed. Int. J. Phytother. Phytopharmacol. 2011, 18:1170-1175.
4. Lai C.H., Teng J.F., Hsu T.H., Lin F.Y., Yang P.W., Lo H.C. Int. J. Med. Mushrooms 2011, 13:227-236.
5. Chan J.Y., Chan E., Chan S.W., Sze S.Y., Chan M.F., Tsui S.H., Leung K.Y., Chan R.Y., Chung I.Y. Pharm. Biol. 2011, 49:1114-1120.
6. Luk S.U., Lee T.K., Liu J., Lee D.T., Chiu Y.T., Ma S., Ng I.O., Wong Y.C., Chan F.L., Ling M.T. PLoS ONE 2011, 6:e19804.
7. Li J., Bao Y., Lam W., Li W., Lu F., Zhu X., Liu J., Wang H. Immunopharmacol. Immunotoxicol. 2008, 30:771-782.
8. Li N., Li L., Fang J.C., Wong J.H., Ng T.B., Jiang Y., Wang C.R., Zhang N.Y., Wen T.Y., Qu L.Y., Lv P.Y., Zhao R., Shi B., Wang Y.P., Wang X.Y., Liu F. Biosci. Rep. 2012, 32:221-228.
9. Wang J., Dong B., Tan Y., Yu S., Bao Y.X. Immunopharmacol. Immunotoxicol. 2013, 35:497-504.
10. Figueiredo R.T., Bittencourt V.C., Lopes L.C., Sassaki G., Barreto-Bergter E. Carbohydr. Res. 2012, 356:260-264.
11. Zhang X., Wang J., Xu Z., Li Z., Feng S., Lu H. Int. Immunopharmacol. 2013, 17:1116-1119.
12. Huang R., Zhang J., Liu Y., Hao Y., Yang C., Wu K., Cao S., Wu C. Mol. Med. Rep. 2013, 8:669-675.
13. Li W., Liu M., Lai S., Xu C., Lu F., Xiao X., Bao Y. Immunopharmacol. Immunotoxicol. 2010, 32:576-584.
14. Verstak B., Stack J., Ve T., Mangan M., Hjerrild K., Jeon J., Stahl R., Latz E., Gay N., Kobe B., Bowie A.G., Mansell A. J. Leukoc. Biol. 2014, 96:427-436.
15. Feng Y., Zhao H., Xu X., Buys E.S., Raher M.J., Bopassa J.C., Thibault H., Scherrer-Crosbie M., Schmidt U., Chao W. Am. J. Physiol. Heart Circul. Physiol. 2008, 295:H1311-H1318.
16. Brown J., Wang H., Hajishengallis G.N., Martin M. J. Dent. Res. 2011, 90:417-427.
17. Lin S.C., Lo Y.C., Wu H. Nature 2010, 465:885-890.
18. Loiarro M., Sette C., Gallo G., Ciacci A., Fanto N., Mastroianni D., Carminati P., Ruggiero V. J. Biol. Chem. 2005, 280:15809-15814.
19. Van Tassell B.W., Seropian I.M., Toldo S., Salloum F.N., Smithson L., Varma A., Hoke N.N., Gelwix C., Chau V., Abbate A. J. Cardiovasc. Pharmacol. 2010, 55:385-390.
20. Loiarro M., Ruggiero V., Sette C. Clin. Lymphoma Myeloma Leuk. 2013, 13:222-226.
21. Loiarro M., Capolunghi F., Fanto N., Gallo G., Campo S., Arseni B., Carsetti R., Carminati P., De Santis R., Ruggiero V., Sette C. J. Leukoc. Biol. 2007, 82:801-810.
22. Li H., Kim W.J., Jiang J., Lee S.H., Youn H.S., Moon E.Y., Kim T.J., Ye S.K., Ryu J.H., Kang T.B., Koppula S., Park P.J., Choi D.K., Lee K.H. Int. Immunopharmacol. 2011, 11:1578-1583.
23. Aziz M., Jacob A., Matsuda A., Wu R., Zhou M., Dong W., Yang W.L., Wang P. PLoS ONE 2011, 6:e27685.
24. Zhang S.S., Nie S.P., Huang D.F., huang J.Q., feng Y.L., Xie M.Y. Food Chem. Toxicol. 2014, 68:239-246.
25. Klein G., Klein E. Ann. N.Y. Acad. Sci. 1956, 63:640-661.
26. Ando I., Tsukumo Y., Wakabayashi T., Akashi S., Miyake K., Kataoka T., Nagai K. Int. Immunopharmacol. 2002, 2:1155-1162.
27. Hsu H.Y., Hua K.F., Lin C.C., Lin C.H., Hsu J., Wong C.H. J. Immunol. 2004, 173:5989-5999.
28. Lu Y., Jiang B.C., Cao D.L., Zhang Z.J., Zhang X., Ji R.R., Gao Y.J. Pain 2014, 155:2618-2629.
29. Goodall K.J., Poon I.K., Phipps S., Hulett M.D. PLOS ONE 2014, 9:e109596.
30. Wong C.K., Bao Y.X., Wong E.L., Leung P.C., Fung K.P., Lam C.W. Am. J. Chin. Med. 2005, 33:381-395.
31. Kim S.J., Park H.J., Shin H.J., Shon D.H., Kim do H., Youn H.S. Int. Immunopharmacol. 2012, 13:403-407.
32. Fu Y., Liu B., Liu J., Liu Z., Liang D., Li F., Li D., Cao Y., Zhang X., Zhang N., Yang Z. Int. Immunopharmacol. 2012, 14:792-798.
33. Takeuchi A., Kamiryou Y., Yamada H., Eto M., Shibata K., Haruna K., Naito S., Yoshikai Y. Int. Immunopharmacol. 2009, 9:1562-1567.
34. Yun C.H., Yang J.S., Kang S.S., Yang Y., Cho J.H., Son C.G., Han S.H. Int. Immunopharmacol. 2007, 7:1192-1198.